Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Is there a renaissance for trapidil?].

H J Mest, E Thomas

    Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
    |April 15, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Trapidil (Rocornal) shows promise beyond treating ischemic heart disease, with potential applications in improving microcirculation and managing hyperlipidemias. This drug does not cause a steal phenomenon, justifying its use as an antianginal agent.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The molecular neuron-glia couple and epileptogenesis.

    Advances in neurology·1999
    Same author

    Rabbit corneal and conjunctival permeability of the novel aldose reductase inhibitors: N-[[4-(benzoylamino)phenyl] sulphonyl]glycines and N-benzoyl-N-phenylglycines.

    The Journal of pharmacy and pharmacology·1999
    Same author

    Colo-cholecystic fistula: an unusual complication of colonic diverticular disease.

    The American journal of gastroenterology·1999
    Same author

    Clinical usefulness of biochemical resorption markers in osteoporosis.

    Annals of clinical biochemistry·1999
    Same author

    Short-term physical risk factors for new episodes of low back pain. Prospective evidence from the South Manchester Back Pain Study.

    Spine·1999
    Same author

    Oral etoposide for patients with advanced adenocarcinoma of the pancreas.

    Investigational new drugs·1999

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Thrombosis Research

    Context:

    • Recent experimental and clinical investigations highlight Trapidil's (Rocornal) multifaceted therapeutic potential.
    • A surge in research, particularly from Japanese authors, necessitates a re-evaluation of Trapidil's clinical applications.
    • Existing research suggests Trapidil's efficacy extends beyond its antianginal properties.

    Purpose:

    • To survey and consolidate recent findings on Trapidil's (Rocornal) applications.
    • To explore potential new indications for Trapidil, including platelet aggregation inhibition and microcirculation improvement.
    • To assess Trapidil's safety profile, specifically its lack of a steal phenomenon.

    Summary:

    • Trapidil (Rocornal) demonstrates efficacy in treating ischemic heart disease and shows promise in inhibiting platelet aggregation.

    Related Experiment Videos

  • The drug is indicated for improving microcirculation and managing hyperlipidemias.
  • Crucially, Trapidil does not induce a steal phenomenon, a significant finding for its antianginal classification.

    • Impact:

    • The findings suggest a potential renaissance for Trapidil (Rocornal) in clinical practice.
    • Reconsidering Trapidil's therapeutic scope may lead to expanded treatment options for cardiovascular and thrombotic conditions.
    • The absence of the steal phenomenon supports Trapidil's continued use and broader application in antianginal therapy.